Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Langton

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
The Medical Journal of Australia|June 26, 2023
Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data studyJoanna Huang, Wasek Faisal, Margaret Brand, et al.
BMJ Open|December 17, 2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year resultsAlfons Torrego, Felix J Herth, Ana M Munoz-Fernandez, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|July 1, 2026
Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatmentRejoy Sabin Thomas, Dennis Thomas, Vanessa M McDonald, et al.
The Journal of Bone and Joint Surgery. American Volume|March 1, 2017
Investigation of Taper Failure in a Contemporary Metal-on-Metal Hip Arthroplasty System Through Examination of Unused and Explanted ProsthesesDavid Langton, Imran Ahmed, Peter Avery, et al.
Allergy|September 23, 2018
The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admissionMark Hew, Joy Lee, Nugroho H Susanto, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe AsthmaDennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal|March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthmaErin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine|September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryErin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
JTO Clinical and Research Reports|April 20, 2026
Treatment Timeliness in Extensive-Stage SCLC and Impact on Survival: A Registry-Based Observational StudyAlison Hiong, Julien Robinson, Eldho Paul, et al.
Internal Medicine Journal|February 28, 2020
Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetingsSteven Maltby, Vanessa M McDonald, John W Upham, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Medical Journal of Australia|June 26, 2023
Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data studyJoanna Huang, Wasek Faisal, Margaret Brand, et al.
BMJ Open|December 17, 2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year resultsAlfons Torrego, Felix J Herth, Ana M Munoz-Fernandez, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|July 1, 2026
Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatmentRejoy Sabin Thomas, Dennis Thomas, Vanessa M McDonald, et al.
The Journal of Bone and Joint Surgery. American Volume|March 1, 2017
Investigation of Taper Failure in a Contemporary Metal-on-Metal Hip Arthroplasty System Through Examination of Unused and Explanted ProsthesesDavid Langton, Imran Ahmed, Peter Avery, et al.
Allergy|September 23, 2018
The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admissionMark Hew, Joy Lee, Nugroho H Susanto, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe AsthmaDennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal|March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthmaErin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine|September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryErin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
JTO Clinical and Research Reports|April 20, 2026
Treatment Timeliness in Extensive-Stage SCLC and Impact on Survival: A Registry-Based Observational StudyAlison Hiong, Julien Robinson, Eldho Paul, et al.
Internal Medicine Journal|February 28, 2020
Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetingsSteven Maltby, Vanessa M McDonald, John W Upham, et al.
Pageof 7